Epstein Secrets

ange. Please contact your Morgan Stanley representative for more details. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement b

Inc. ("FB" / NASDAQ) IPO Facebook. Inc. (FB / Nasdaq) Facebook's mission is to make the world more open and connected. Morgan Stanley, El Morgan, Goldman, Sachs & Co. BofA Merrill Lynch, Barclays Capital, Allen & Company LLC, Citigroup, Credit Suisse, Deutsche Bank Securities, RBC Capital Markets, Wells Fargo Sec

f Common Stock CAMBRIDGE, Mass.—(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced the filing of a Registration Statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of shares of its common stock. All of the shares to be sold in the proposed offering will be offered by Found

ffered by Foundation Medicine. Foundation Medicine has applied for a listing of its common stock on The NASDAQ Stock Market under the symbol "FMI" Goldman, Sachs & Co. and J.P. Morgan Securities, LLC will act as joint book-running managers of the offering. A copy of the preliminary prospectus relating to this offer

controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is 11.4 http://vanv. see. gov/Archi vecledgaddataht83980/00011 93 1251 5334479/d31022ds la.htmi 1 0/14/201 5 9:06:38 AM] CONF

enner & Smith Incorporated, Citigroup Global Markets Inc.. Deutsche Bank Securities Inc., Barclays Capital Inc., Credit Suisse Securities (USA) LLC, Goldman, Sachs & Co., HSBC Securities (USA) Inc., Wells Fargo Securities, LLC and KKR Capital Markets LLC. On December 2, 2013, Holdings issued approximately $1.4 billio

s. See the section Wed 'Risk Factors on page 25 to read about factors you should consider before buying shares of our Class A common stock. Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any repres

ring price less the underwriting discount. The underwriters expect to deliver the shares against payment in New York. New York on or about . 2015. Goldman, Sachs & Co. Morgan Stanley J.P. Morgan Barclays Deutsche Bank Securities Jefferies RBC Capital Markets Stifel LOYAL3 Securities SMBC Nikko Prospectus d

ing their usefulness as a comparative measure; and @ they do not comply with the requirements of Item 10(e) of Regulation S-K or Regulation G of the Securities and Exchange Commission (“SEC"). Because of these limitations, EBITDA, Adjusted EBITDA and Adjusted EBITDAR should not be considered as measures of discretionary cash avail

neral Partner (“Class A Share’), for $1,000 per Unit. We are offering the Units on a strictly confidential basis pursuant to a private placement with Goldman, Sachs & Co. and Credit Suisse acting as placement agents (the “Agents"), subject to various conditions, exclusively to accredited investors. We intend to use the